LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

US Labs Increase COVID-19 Testing Capacity but Facing Shortage of Supplies, Finds NILA Survey

By LabMedica International staff writers
Posted on 06 Oct 2020
Illustration
Illustration
A survey of community and regional laboratories in the US has revealed a potential collective increase in COVID-19 testing capacity, although difficulties persist in accessing the necessary testing supplies.

The National Independent Laboratory Association (NILA St. Louis, MO, USA) conducted a survey of 12 twelve community and regional laboratories that revealed shortages of test kits, reagents, and other materials, such as plastic pipette tips, without which they were unable to perform the promised number of tests. In spite of an increase in their COVID-19 testing capacity, these labs do not have access to the supplies and materials necessary to perform critical COVID-19 tests. For example, one regional laboratory reported an allocation from a manufacturer of enough reagents to process 500 tests per day, although it has a capacity for performing at least 3,000 tests per day.

The NILA has stressed that speedy test results are critical for isolating infected patients and mitigating the spread of COVID-19. Community and regional laboratories report they can provide test results within one to two days which is significantly faster than the reported wait times experienced by most of the US population in recent weeks and months. According to the NILA, mitigating supply shortages will help increase the number of tests provided as well as the speed with which test results are delivered.

“The federal government must do whatever it can to help alleviate the testing supply shortages NILA members are experiencing,” said Mark Birenbaum, Ph.D., executive director, NILA. “We won’t emerge from this pandemic unless we focus on testing, and community and regional independent laboratories are key to scaling up our nation’s testing capacity. We have not seen transparency from the federal government regarding where test supplies are being allocated and how community labs can increase their access to these essential supplies.”

Related Links:
National Independent Laboratory Association

Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Capillary Blood Collection Tube
IMPROMINI M3

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more